Myasthenia Gravis- a Disguised Cause of Recurrent Respiratory Failure: A Rare Case Treated Successfully at National Hospital Sri Lanka

M. N. S. K. Perera *

National Hospital of Sri Lanka, Sri Lanka.

D. H. H. L. Sathischandra

National Hospital of Sri Lanka, Sri Lanka.

I. A. Maharambe

National Hospital of Sri Lanka, Sri Lanka.

N. M. Ellawala

National Hospital of Sri Lanka, Sri Lanka.

*Author to whom correspondence should be addressed.


Abstract

Myasthenia gravis is an autoimmune disease, due to the presence of antibodies against the proteins in the post-synaptic muscle membrane, which leads to localized or generalized muscle weakness.

Presentation of myasthenia gravis could vary from patient to patient, while ocular muscle weakness is the most common form.

Here, a case of a young male who presented with recurrent respiratory failure is reported.

He had respiratory failure as the only clinical manifestation of myasthenia gravis. It describes respiratory weakness as a rare isolated initial presentation of this disorder. This case highlights the importance of prompt diagnosis of this condition, considering the variable presentations, to achieve a successful therapeutic outcome.

Keywords: Myasthenia gravis, respiratory failure, acetylcholine receptor antibodies


How to Cite

Perera, M. N. S. K., Sathischandra, D. H. H. L., Maharambe, I. A., & Ellawala , N. M. (2024). Myasthenia Gravis- a Disguised Cause of Recurrent Respiratory Failure: A Rare Case Treated Successfully at National Hospital Sri Lanka. Asian Journal of Case Reports in Medicine and Health, 7(1), 22–25. Retrieved from https://journalajcrmh.com/index.php/AJCRMH/article/view/182

Downloads

Download data is not yet available.

References

Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJGM. Myasthenia gravis. Nat Rev Dis Primers. 2019;5(1):30.

Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. J Clin Med. 2021; 10(11):2235.

García Estévez DA, Pardo Fernández J. Myasthenia gravis. Update on diagnosis and therapy. Med Clin (Barc). English, Spanish. 2023;161(3):119-127.

Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest. 2006;116(11):2843-54.

Grob D, Arsura L, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Annals of the New York Academy of Sciences. 1987;505:472–499.

Mishra AK, Varma A. Myasthenia Gravis: A systematic review. Cureus. 2023;15(12): e50017.

Pal S, Sanyal D. Jaw muscle weakness: A differential indicator of neuromuscular weakness-preliminary observations. Muscle and Nerve. 2011;43 (6):807–811.

Jayam Trouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J. Myasthenia gravis: a review. Autoimmune Dis. 2012;2012:874680.

Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol. 2004;24(1):75-81.

Dushay KM, Zibrak JD, Jensen WA. Myasthenia gravis presenting as isolated respiratory failure. Chest. 1990;97(1):232-4.

Zulueta JJ, Fanburg BL. Respiratory dysfunction in myasthenia gravis. Clin Chest Med. 1994;15(4):683-91.

Qureshi AI, Choundry MA, Mohammad Y, Chua HC, Yahia AM, Ulatowski JA, Krendel DA, Leshner RT. Respiratory failure as a first presentation of myasthenia gravis. Med Sci Monit. 2004;10(12): CR684-9.